Despite these observed differences , the effects of ticagrelor versus clopidogrel were not significantly different between Asians and non-Asians with respect to the primary efficacy outcome ( hazard ratio for Asians vs non-Asians , @ -LSB- @ % CI @-@ @ -RSB- vs @ -LSB- @ % CI @-@ @ -RSB- , P = @ ) , net clinical benefit ( @ -LSB- @ % CI @-@ @ -RSB- vs @ -LSB- @ % CI @-@ @ -RSB- , P = @ ) , or individual efficacy end points .